Edward L Hannan1, Ye Zhong1, Peter B Berger2, Alice K Jacobs3, Gary Walford4, Frederick S K Ling5, Ferdinand J Venditti6, Spencer B King7. 1. University at Albany, State University of New York, Rensselaer. 2. Retired. 3. Boston Medical Center, Boston, Massachusetts. 4. Johns Hopkins University, Baltimore, Maryland. 5. University of Rochester Medical Center, Rochester, New York. 6. Albany Medical Center, Albany, New York. 7. St Joseph's Health System, Atlanta, Georgia.
Abstract
Importance: Many studies have compared outcomes for incomplete revascularization (IR) among patients undergoing percutaneous coronary interventions (PCI), but little is known about whether outcomes are related to the nature of the IR. Objective: To determine whether some coronary vessel characteristics are associated with worse outcomes in patients with PCI with IR. Design, Setting, and Participants: New York's PCI registry was used to examine mortality (median follow-up, 3.4 years) as a function of the number of vessels that were incompletely revascularized, the stenosis in those vessels, and whether the proximal left anterior descending artery was incompletely revascularized after controlling for other factors associated with mortality for patients with and without ST-elevation myocardial infarction (STEMI). This was a multicenter study (all nonfederal PCI hospitals in New York State) that included 41 639 New York residents with multivessel coronary artery disease undergoing PCI in New York State between January 1, 2010, and December 31, 2012. Exposures: Percutaneous coronary interventions, with complete and incomplete revascularization. Main Outcomes and Measures: Medium-term mortality. Results: For patients with STEMI, the mean age was 62.8 years; 26.2% were women, 11.9% were Hispanic, and 81.5% were white. For other patients, the mean age was 66.6 years, 29.1% were women, 11.3% were Hispanic, and 79.1% were white. Incomplete revascularization was very common (78% among patients with STEMI and 71% among other patients). Patients with IR in a vessel with at least 90% stenosis were at higher risk than other patients with IR. This was not significant among patients with STEMI (17.18% vs 12.86%; adjusted hazard ratio [AHR], 1.16; 95% CI, 0.99-1.37) and significant among patients without STEMI (17.71% vs 12.96%; AHR, 1.15; 95% CI, 1.07-1.24). Similarly, patients with IR in 2 or more vessels had higher mortality than patients with completely revascularization and higher mortality than other patients with IR among patients with STEMI (20.37% vs 14.39%; AHR, 1.35; 95% CI, 1.15-1.59) and among patients without STEMI (20.10% vs 12.86%; AHR, 1.17; 95% CI, 1.09-1.59). Patients with proximal left anterior descending artery vessel IR had higher mortality than other patients with IR (20.09% vs 14.67%; AHR, 1.31; 95% CI, 1.04-1.64 for patients with STEMI and 20.78% vs 15.62%; AHR, 1.11; 95% CI, 1.01-1.23 for patients without STEMI). More than 20% of all PCI patients had IR of 2 or more vessels and more than 30% had IR with more than 90% stenosis. Conclusions and Relevance: Patients with IR are at higher risk of mortality if they have IR with at least 90% stenosis, IR in 2 or more vessels, or proximal left anterior descending IR.
Importance: Many studies have compared outcomes for incomplete revascularization (IR) among patients undergoing percutaneous coronary interventions (PCI), but little is known about whether outcomes are related to the nature of the IR. Objective: To determine whether some coronary vessel characteristics are associated with worse outcomes in patients with PCI with IR. Design, Setting, and Participants: New York's PCI registry was used to examine mortality (median follow-up, 3.4 years) as a function of the number of vessels that were incompletely revascularized, the stenosis in those vessels, and whether the proximal left anterior descending artery was incompletely revascularized after controlling for other factors associated with mortality for patients with and without ST-elevation myocardial infarction (STEMI). This was a multicenter study (all nonfederal PCI hospitals in New York State) that included 41 639 New York residents with multivessel coronary artery disease undergoing PCI in New York State between January 1, 2010, and December 31, 2012. Exposures: Percutaneous coronary interventions, with complete and incomplete revascularization. Main Outcomes and Measures: Medium-term mortality. Results: For patients with STEMI, the mean age was 62.8 years; 26.2% were women, 11.9% were Hispanic, and 81.5% were white. For other patients, the mean age was 66.6 years, 29.1% were women, 11.3% were Hispanic, and 79.1% were white. Incomplete revascularization was very common (78% among patients with STEMI and 71% among other patients). Patients with IR in a vessel with at least 90% stenosis were at higher risk than other patients with IR. This was not significant among patients with STEMI (17.18% vs 12.86%; adjusted hazard ratio [AHR], 1.16; 95% CI, 0.99-1.37) and significant among patients without STEMI (17.71% vs 12.96%; AHR, 1.15; 95% CI, 1.07-1.24). Similarly, patients with IR in 2 or more vessels had higher mortality than patients with completely revascularization and higher mortality than other patients with IR among patients with STEMI (20.37% vs 14.39%; AHR, 1.35; 95% CI, 1.15-1.59) and among patients without STEMI (20.10% vs 12.86%; AHR, 1.17; 95% CI, 1.09-1.59). Patients with proximal left anterior descending artery vessel IR had higher mortality than other patients with IR (20.09% vs 14.67%; AHR, 1.31; 95% CI, 1.04-1.64 for patients with STEMI and 20.78% vs 15.62%; AHR, 1.11; 95% CI, 1.01-1.23 for patients without STEMI). More than 20% of all PCI patients had IR of 2 or more vessels and more than 30% had IR with more than 90% stenosis. Conclusions and Relevance: Patients with IR are at higher risk of mortality if they have IR with at least 90% stenosis, IR in 2 or more vessels, or proximal left anterior descending IR.
Authors: Gregg F Rosner; Ajay J Kirtane; Philippe Genereux; Alexandra J Lansky; Ecaterina Cristea; Bernard J Gersh; Giora Weisz; Helen Parise; Martin Fahy; Roxana Mehran; Gregg W Stone Journal: Circulation Date: 2012-05-01 Impact factor: 29.690
Authors: Edward L Hannan; Michael Racz; David R Holmes; Spencer B King; Gary Walford; John A Ambrose; Samin Sharma; Stanley Katz; Luther T Clark; Robert H Jones Journal: Circulation Date: 2006-05-15 Impact factor: 29.690
Authors: Leonard Schwartz; Marnie Bertolet; Frederick Feit; Francisco Fuentes; Edward Y Sako; Mehrdad S Toosi; Charles J Davidson; Fumiaki Ikeno; Spencer B King Journal: Circ Cardiovasc Interv Date: 2012-04-10 Impact factor: 6.546
Authors: Edward L Hannan; Ye Zhong; Alice K Jacobs; Frederick S K Ling; Peter B Berger; Gary Walford; Ferdinand J Venditti; Spencer B King Journal: Am Heart J Date: 2017-02-08 Impact factor: 4.749
Authors: Chuntao Wu; Anne-Marie Dyer; Gary Walford; David R Holmes; Spencer B King; Nicholas J Stamato; Samin Sharma; Alice K Jacobs; Ferdinand J Venditti; Edward L Hannan Journal: Am J Cardiol Date: 2013-06-04 Impact factor: 2.778
Authors: Kristina Hambraeus; Karin Jensevik; Bo Lagerqvist; Bertil Lindahl; Roland Carlsson; Ramin Farzaneh-Far; Thomas Kellerth; Elmir Omerovic; Gregg Stone; Christoph Varenhorst; Stefan James Journal: JACC Cardiovasc Interv Date: 2016-02-08 Impact factor: 11.195
Authors: Edward L Hannan; Chuntao Wu; Gary Walford; David R Holmes; Robert H Jones; Samin Sharma; Spencer B King Journal: JACC Cardiovasc Interv Date: 2009-01 Impact factor: 11.195
Authors: Vinayak Nagaraja; Sze-Yuan Ooi; James Nolan; Adrian Large; Mark De Belder; Peter Ludman; Rodrigo Bagur; Nick Curzen; Takashi Matsukage; Fuminobu Yoshimachi; Chun Shing Kwok; Colin Berry; Mamas A Mamas Journal: J Am Heart Assoc Date: 2016-12-16 Impact factor: 5.501
Authors: Deborah H Kwon; Nancy A Obuchowski; Thomas H Marwick; Venu Menon; Brian Griffin; Scott D Flamm; Rory Hachamovitch Journal: J Am Heart Assoc Date: 2018-11-20 Impact factor: 5.501
Authors: Raffaele Piccolo; Kaare H Bonaa; Orestis Efthimiou; Olivier Varenne; Philip Urban; Christoph Kaiser; Lorenz Räber; Adam de Belder; Wouter Remkes; Arnoud W J Van't Hof; Goran Stankovic; Pedro A Lemos; Tom Wilsgaard; Jörg Reifart; Alfredo E Rodriguez; Expedito E Ribeiro; Patrick W J C Serruys; Alex Abizaid; Manel Sabaté; Robert A Byrne; Jose M de la Torre Hernandez; William Wijns; Giovanni Esposito; Peter Jüni; Stephan Windecker; Marco Valgimigli Journal: J Am Heart Assoc Date: 2021-10-08 Impact factor: 5.501